MicroRNA Profiling in Aging Brain of PSEN1/PSEN2 Double Knockout Mice

被引:0
|
作者
Suji Ham
Tae Kyoo Kim
Sangjoon Lee
Ya-Ping Tang
Heh-In Im
机构
[1] Korea Institute of Science and Technology (KIST),Convergence Research Center for Diagnosis, Treatment and Care System of Dementia
[2] Korea University of Science and Technology,Division of Bio
[3] Boston University,Medical Science &Technology, KIST School
[4] Korea Institute of Science and Technology (KIST),Department of Biology
[5] Louisiana State University Health New Orleans Sciences Center,Center for Neuroscience, Brain Science Institute
来源
Molecular Neurobiology | 2018年 / 55卷
关键词
MicroRNA; PSEN dKO mouse; Alzheimer’s disease; Aging; Microarray; Neurodegeneration;
D O I
暂无
中图分类号
学科分类号
摘要
MicroRNAs are small non-coding RNAs that function as regulators of gene expression. The altered expression of microRNAs influences the pathogenesis of Alzheimer’s disease. Many researchers have focused on studies based on the relatively distinctive etiology of familial Alzheimer’s disease due to the absence of risk factors in the pathogenesis of sporadic Alzheimer’s disease. Although there is a limitation in Alzheimer’s disease studies, both Alzheimer’s disease types have a common risk factor—aging. No study to date has examined the aging factor in Alzheimer’s disease animal models with microRNAs. To investigate the effect of aging on the changes in microRNA expressions in the Alzheimer’s disease animal model, we selected 37 hippocampal microRNAs whose expression in 12- and 18-month aged mice changed significantly using microRNA microarray. On the basis of bioinformatics databases, 30 hippocampal microRNAs and their putative targets of PSEN1/PSEN2 double knockout mice were included in 28 pathways such as the wnt signaling pathway and ubiquitin-mediated proteolysis pathway. Cortical microRNAs and its putative targets involved in pathological aging were included in only four pathways such as the heparin sulfate biosynthesis. The altered expressions of these hippocampal microRNAs were associated to the imbalance between neurotoxic and neuroprotective functions and seemed to affect neurodegeneration in PSEN1/PSEN2 double knockout mice more severely than in wild-type mice. This microRNA profiling suggests that microRNAs play potential roles in the normal aging process, as well as in the Alzheimer’s disease process.
引用
收藏
页码:5232 / 5242
页数:10
相关论文
共 50 条
  • [1] MicroRNA Profiling in Aging Brain of PSEN1/PSEN2 Double Knockout Mice
    Ham, Suji
    Kim, Tae Kyoo
    Lee, Sangjoon
    Tang, Ya-Ping
    Im, Heh-In
    MOLECULAR NEUROBIOLOGY, 2018, 55 (06) : 5232 - 5242
  • [2] Mutational analysis of PSEN1, PSEN2 and APP in a Japanese population
    Wakutani, Y
    Isoe-Wada, K
    Kusumi, M
    Adachi, Y
    Nakashima, K
    Urakami, K
    Sakuma, K
    Watanabe, K
    NEUROBIOLOGY OF AGING, 2004, 25 : S515 - S515
  • [3] The pathogenicity of PSEN2 variants is tied to Aβ production and homology to PSEN1
    Liu, Lei
    Schultz, Stephanie A.
    Saba, Adriana
    Yang, Hyun-Sik
    Li, Amy
    Selkoe, Dennis J.
    Chhatwal, Jasmeer P.
    ALZHEIMERS & DEMENTIA, 2024, 20 (12) : 8867 - 8877
  • [4] Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos
    Nornes, Svonhild
    Newman, Morgan
    Wells, Simon
    Verdile, Giuseppe
    Martins, Ralph N.
    Lardelli, Michael
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (16) : 2791 - 2801
  • [5] PSEN1 and PSEN2 Gene Expression in Alzheimer's Disease Brain: A New Approach
    Delabio, Roger
    Rasmussen, Lucas
    Mizumoto, Igor
    Viani, Gustavo-Arruda
    Chen, Elizabeth
    Villares, Joao
    Costa, Isabela-Bazzo
    Turecki, Gustavo
    Linde, Sandra Aparecido
    Smith, Marilia Cardoso
    Payao, Spencer-Luiz
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (03) : 757 - 760
  • [6] Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
    Hsu, Simon
    Pimenova, Anna A.
    Hayes, Kimberly
    Villa, Juan A.
    Rosene, Matthew J.
    Jere, Madhavi
    Goate, Alison M.
    Karch, Celeste M.
    NEUROBIOLOGY OF DISEASE, 2020, 139
  • [7] Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients
    Lohmann, Ebba
    Guerreiro, Rita J.
    Erginel-Unaltuna, Nihan
    Gurunlian, Nicole
    Bilgic, Basar
    Gurvit, Hakan
    Hanagasi, Hasmet A.
    Luu, Nga
    Emre, Murat
    Singleton, Andrew
    NEUROBIOLOGY OF AGING, 2012, 33 (08)
  • [8] Clinical and Neuroimaging Characterization of Chinese Dementia Patients with PSEN1 and PSEN2 Mutations
    Shi, Zhihong
    Wang, Ying
    Liu, Shuai
    Liu, Mengyuan
    Liu, Shuling
    Zhou, Yuying
    Wang, Jinhuan
    Cai, Li
    Huo, Ya Ruth
    Gao, Shuo
    Ji, Yong
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2015, 39 (1-2) : 32 - 40
  • [9] Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease
    Course, Meredith M.
    Gudsnuk, Kathryn
    Keene, C. Dirk
    Bird, Thomas D.
    Jayadev, Suman
    Valdmanis, Paul N.
    BRAIN, 2023, 146 (02) : 507 - 518
  • [10] Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro
    Raut, Snehal
    Patel, Ronak
    Al-Ahmad, Abraham J.
    FLUIDS AND BARRIERS OF THE CNS, 2021, 18 (01)